美国放射学院(American College of Radiology,ACR)偶发病变委员会(Incidental Findings Committee,IFC)发布了针对CT偶发性肾脏肿块的管理建议。这些建议更新了美国放射学院杂志(JACR)2010年发布的关于肾上腺、肾脏、肝脏及胰腺偶发病...美国放射学院(American College of Radiology,ACR)偶发病变委员会(Incidental Findings Committee,IFC)发布了针对CT偶发性肾脏肿块的管理建议。这些建议更新了美国放射学院杂志(JACR)2010年发布的关于肾上腺、肾脏、肝脏及胰腺偶发病变管理白皮书的肾脏部分内容。肾脏亚组委员会(包括6位腹部放射学家和1位泌尿科医师)制订这份管理流程。这些建议结合已发表的文献和专家意见,通过非正式的反复协商达成共识。文中每张流程图描述需要进一步行影像学检查、随访或转诊治疗的肾脏肿块的影像特征。我们的目的是对偶发性肾脏肿块的管理提供指导建议,从而改善医疗质量。展开更多
The diagnosis of small renal masses(SRMs) continues to increase likely attributable to widespread use of axial cross-sectional imaging. Many of these SRMs present in elderly patients with abnormal baseline renal funct...The diagnosis of small renal masses(SRMs) continues to increase likely attributable to widespread use of axial cross-sectional imaging. Many of these SRMs present in elderly patients with abnormal baseline renal function. Such patients are at risk for further decline following therapeutic intervention. Renal thermal ablation presents one approach for management of SRMs whereby tumors are treated in situ without need for global renal ischemia. These treatment characteristics contribute to favorable renal function outcomes following kidney tumor ablation particularly in patients with an anatomic or functional solitary renal unit.展开更多
文摘美国放射学院(American College of Radiology,ACR)偶发病变委员会(Incidental Findings Committee,IFC)发布了针对CT偶发性肾脏肿块的管理建议。这些建议更新了美国放射学院杂志(JACR)2010年发布的关于肾上腺、肾脏、肝脏及胰腺偶发病变管理白皮书的肾脏部分内容。肾脏亚组委员会(包括6位腹部放射学家和1位泌尿科医师)制订这份管理流程。这些建议结合已发表的文献和专家意见,通过非正式的反复协商达成共识。文中每张流程图描述需要进一步行影像学检查、随访或转诊治疗的肾脏肿块的影像特征。我们的目的是对偶发性肾脏肿块的管理提供指导建议,从而改善医疗质量。
文摘The diagnosis of small renal masses(SRMs) continues to increase likely attributable to widespread use of axial cross-sectional imaging. Many of these SRMs present in elderly patients with abnormal baseline renal function. Such patients are at risk for further decline following therapeutic intervention. Renal thermal ablation presents one approach for management of SRMs whereby tumors are treated in situ without need for global renal ischemia. These treatment characteristics contribute to favorable renal function outcomes following kidney tumor ablation particularly in patients with an anatomic or functional solitary renal unit.